CAS: 5118-29-6 - Melitracen
Formula:C21H25N
InChI:InChI=1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3
InChI key:InChIKey=GWWLWDURRGNSRS-UHFFFAOYSA-N
SMILES:C=1C=CC2=C(C1)C(=CCCN(C)C)C=3C=CC=CC3C2(C)C
- Synonyms:
- 1-Propanamine, 3-(10,10-dimethyl-9(10H)-anthracenylidene)-N,N-dimethyl-
- 3-(10,10-Dimethyl-9(10H)-anthracenylidene)-N,N-dimethyl-1-propanamine
- 9,10-Dihydro-10,10-dimethyl-9-(3-dimethylaminopropylidene)anthracene
- 9-(3-Dimethylaminopropylidene)-10,10-dimethyl-9,10-dihydroanthracene
- 9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene
- 9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene [Italian]
- Adaptol
- Brn 1980107
- Dixeran
- Melitracene
- See more synonyms
- Melitracene [INN-French]
- Melitraceno
- Melitraceno [INN-Spanish]
- Melitracenum
- Melitracenum [INN-Latin]
- N 7001
- N,N,10,10-Tetramethyl-delta(sup 9(10),gamma)-anthracenepropylamine
- N,N-Dimethyl-3-(10,10-dimethyl-9(10H)-anthrylidene)propylamine
- Thymeol
- Trausabun
- U-24973
- delta-(sup 9(10),gamma)-Anthracenepropylamine, N,N,10,10-tetramethyl-
- Δ<sup>9(10</sup><sup>H</sup><sup>),γ</sup>-Anthracenepropylamine, N,N,10,10-tetramethyl-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Melitracen REF: TM-T20017CAS: 5118-29-6 | - - - | 1,437.00 €~2,364.00 € | Tue 10 Dec 24 | |
Melitracen REF: 3D-FAA11829CAS: 5118-29-6 | Min. 95% | To inquire | Tue 14 Jan 25 |
Melitracen
CAS:5118-29-6
Melitracen is a tricyclic antidepressant.
Formula:
C21H25N
Color and Shape:
Solid
Molecular weight:
291.43
Ref: TM-T20017
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Melitracen
CAS:5118-29-6
Melitracen is a new drug that has been developed to treat inflammatory bowel disease. It …
Formula:
C21H25N
Purity:
Min. 95%
Molecular weight:
291.4 g/mol
Ref: 3D-FAA11829
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025